news

New publication in European Respiratory Review

Nov 18, 2026
Our systematic review and meta-analysis published in the European Respiratory Review has compared the clinical relevance, radiological manifestations and treatment outcomes of pulmonary disease caused by three major species of the Mycobacterium avium complex (MAC): M. avium, M. intracellulare and M. chimaera.

The analysis included 134 studies and 46,980 patients, making it one of the largest comparative assessments of species-specific MAC pulmonary disease (MAC-PD) to date. The findings showed that M. avium and M. intracellulare had remarkably similar clinical relevance, with approximately 54% of pulmonary isolates associated with clinically relevant disease. In contrast, the clinical relevance of M. chimaera was substantially lower, at 17.8%.

Nodular bronchiectatic disease was the predominant radiological presentation across all three species. Furthermore, treatment success, culture conversion, relapse rates and mortality were broadly comparable between patients with M. avium and M. intracellulare infections. Patients with M. chimaera, however, were less frequently treated.

These findings suggest that M. avium and M. intracellulare have similar clinical and prognostic profiles, despite being distinct species. The lower clinical relevance observed with M. chimaera highlights the importance of accurate molecular species identification. Improved differentiation may help refine the assessment of pathogenicity and support more individualised clinical management of patients with MAC-PD.

You can find the full publication via the journal's homepage, PubMed or the MIRU website.